GlassScriptPhysician profile
Laura C Mcclendon
NPI 1184836512
$754.84
in general payments reported to CMS, 2019-2025
17 companies · $112 in 2025
The $112 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $145 · 2021: $141 · 2022: $57.17 · 2023: $56.80 · 2024: $93.53 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $124.95 | 2020-2023 | Cotempla Xr-Odt |
| Cranial Technologies, INC | $117.51 | 2019-2025 | Doc Band |
| Tris Pharma INC | $66.68 | 2019-2025 | Onyda Xr |
| Genentech USA, INC. | $65.96 | 2019-2021 | |
| Biomarin Pharmaceutical INC. | $58.36 | 2024-2025 | Voxzogo 1.2mg |
| Pfizer INC. | $53.41 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $45.42 | 2020-2024 | Gardasil 9, Gardasil, M-M-R II |
| Adlon Therapeutics L.P. | $44.44 | 2020-2021 | |
| Sobi, INC | $43.40 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $22.88 | 2020 | |
| Cipher Pharmaceuticals US LLC | $20.87 | 2025 | Natroba, Spinosad |
| Corium, LLC | $20.53 | 2022-2023 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $16.52 | 2023 | Flumist Quadrivalent |
| Galderma Laboratories, L.P. | $16.18 | 2021 | |
| Ironshore Pharmaceuticals INC. | $14.72 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $11.87 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Mcclendon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.